MicroRNA-based potential diagnostic, prognostic and therapeutic applications in triple-negative breast cancer
Triple-negative breast cancer (TNBC) is a distinct subtype of breast cancer characterized by high recurrence rates and poor prognosis compared to other breast cancers. MicroRNAs (miRNAs) are small non-coding RNAs that regulate the expression of various post-transcriptional gene and silence a broad s...
Main Authors: | Qian Tang, Hu Ouyang, Dongxiu He, Cuiyun Yu, Guotao Tang |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2019-12-01
|
Series: | Artificial Cells, Nanomedicine, and Biotechnology |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/21691401.2019.1638791 |
Similar Items
-
Regulation of Inflammasome by microRNAs in Triple-Negative Breast Cancer: New Opportunities for Therapy
by: Liliana-Roxana Balahura (Stămat), et al.
Published: (2023-02-01) -
High Expression of microRNA-223 Indicates a Good Prognosis in Triple-Negative Breast Cancer
by: Li Chen, et al.
Published: (2021-04-01) -
MicroRNA-27b-3p Promotes Tumor Progression and Metastasis by Inhibiting Peroxisome Proliferator-Activated Receptor Gamma in Triple-Negative Breast Cancer
by: Song-Jie Shen, et al.
Published: (2020-08-01) -
A panel of miRNAs as prognostic markers for African-American patients with triple negative breast cancer
by: Safaa Turkistani, et al.
Published: (2021-07-01) -
Functional exosome-mediated co-delivery of doxorubicin and hydrophobically modified microRNA 159 for triple-negative breast cancer therapy
by: Chunai Gong, et al.
Published: (2019-09-01)